» Articles » PMID: 21056979

Overexpression of Glyoxalase-I Reduces Hyperglycemia-induced Levels of Advanced Glycation End Products and Oxidative Stress in Diabetic Rats

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2010 Nov 9
PMID 21056979
Citations 93
Authors
Affiliations
Soon will be listed here.
Abstract

The reactive advanced glycation end product (AGE) precursor methylglyoxal (MGO) and MGO-derived AGEs are associated with diabetic vascular complications and also with an increase in oxidative stress. Glyoxalase-I (GLO-I) transgenic rats were used to explore whether overexpression of this MGO detoxifying enzyme reduces levels of AGEs and oxidative stress in a rat model of diabetes. Rats were made diabetic with streptozotocin, and after 12 weeks, plasma and multiple tissues were isolated for analysis of AGEs, carbonyl stress, and oxidative stress. GLO-I activity was significantly elevated in multiple tissues of all transgenic rats compared with wild-type (WT) littermates. Streptozotocin treatment resulted in a 5-fold increase in blood glucose concentrations irrespective of GLO-I overexpression. Levels of MGO, glyoxal, 3-deoxyglucosone, AGEs, and oxidative stress markers nitrotyrosine, malondialdehyde, and F2-isoprostane were elevated in the diabetic WT rats. In diabetic GLO-I rats, glyoxal and MGO composite scores were significantly decreased by 81%, and plasma AGEs and oxidative stress markers scores were significantly decreased by ∼50%. Hyperglycemia induced a decrease in protein levels of the mitochondrial oxidative phosphorylation complex in the gastrocnemius muscle, which was accompanied by an increase in the lipid peroxidation product 4-hydroxy-2-nonenal, and this was counteracted by GLO-I overexpression. This study shows for the first time in an in vivo model of diabetes that GLO-I overexpression reduces hyperglycemia-induced levels of carbonyl stress, AGEs, and oxidative stress. The reduction of oxidative stress by GLO-I overexpression directly demonstrates the link between glycation and oxidative stress.

Citing Articles

Modelling the effects of elevated methylglyoxal levels on vascular and metabolic complications.

Vangrieken P, Scheijen J, Schiffers P, van de Waarenburg M, Foulquier S, Schalkwijk C Sci Rep. 2025; 15(1):6025.

PMID: 39972072 PMC: 11839914. DOI: 10.1038/s41598-025-90661-5.


Early Methylglyoxal Exposure Leads to Worsened Cardiovascular Function in Young Rats.

Ferreira-Junior M, Cavalcante K, Costa J, Bessa A, Amaro A, de Castro C Nutrients. 2024; 16(13).

PMID: 38999777 PMC: 11243563. DOI: 10.3390/nu16132029.


Bidirectional relationship between pancreatic cancer and diabetes mellitus: a comprehensive literature review.

Sapoor S, Nageh M, Shalma N, Sharaf R, Haroun N, Salama E Ann Med Surg (Lond). 2024; 86(6):3522-3529.

PMID: 38846873 PMC: 11152885. DOI: 10.1097/MS9.0000000000002036.


Methylglyoxal and Advanced Glycation End Products (AGEs): Targets for the Prevention and Treatment of Diabetes-Associated Bladder Dysfunction?.

Oliveira A, de Oliveira M, Monica F, Antunes E Biomedicines. 2024; 12(5).

PMID: 38790901 PMC: 11118115. DOI: 10.3390/biomedicines12050939.


Modulatory effects of rutin and vitamin A on hyperglycemia induced glycation, oxidative stress and inflammation in high-fat-fructose diet animal model.

Iqbal A, Hafeez Kamran S, Siddique F, Ishtiaq S, Hameed M, Manzoor M PLoS One. 2024; 19(5):e0303060.

PMID: 38723008 PMC: 11081234. DOI: 10.1371/journal.pone.0303060.


References
1.
Beisswenger P, Howell S, Nelson R, Mauer M, Szwergold B . Alpha-oxoaldehyde metabolism and diabetic complications. Biochem Soc Trans. 2003; 31(Pt 6):1358-63. DOI: 10.1042/bst0311358. View

2.
Marti R, Varela E, Segura R, Alegre J, Surinach J, Pascual C . Determination of D-lactate by enzymatic methods in biological fluids: study of interferences. Clin Chem. 1997; 43(6 Pt 1):1010-5. View

3.
van de Kerkhof J, Schalkwijk C, Konings C, Cheriex E, van der Sande F, Scheffer P . Nepsilon-(carboxymethyl)lysine, Nepsilon-(carboxyethyl)lysine and vascular cell adhesion molecule-1 (VCAM-1) in relation to peritoneal glucose prescription and residual renal function; a study in peritoneal dialysis patients. Nephrol Dial Transplant. 2004; 19(4):910-6. DOI: 10.1093/ndt/gfh004. View

4.
Miller A, Smith D, Bhat M, Nagaraj R . Glyoxalase I is critical for human retinal capillary pericyte survival under hyperglycemic conditions. J Biol Chem. 2006; 281(17):11864-71. DOI: 10.1074/jbc.M513813200. View

5.
Brownlee M . Biochemistry and molecular cell biology of diabetic complications. Nature. 2001; 414(6865):813-20. DOI: 10.1038/414813a. View